High Costs Hit Fastener Firms
The cost of meeting new Quality Control Orders (QCOs) for fasteners presents a significant financial challenge. Businesses face expenses potentially reaching ₹1 lakh per license. Establishing dedicated testing labs can cost upwards of ₹30-40 lakh, a prohibitive sum for many small and medium-sized enterprises (MSMEs) operating on tighter margins and with limited capital.
Industry Impact
These rising compliance burdens have already prompted some foreign suppliers to withdraw from the Indian market. This reduction in the supplier base leads to less availability of specialized parts and allows remaining certified firms to raise prices. Consequently, input costs for key industries like automotive and infrastructure are increasing, directly counteracting the 'Make in India' agenda.
Rules Clash with Industry Needs
The mandated "one-product-one-license" system creates operational friction. It is misaligned with the fastener industry's reality, where manufacturers often produce dozens of variants in small batches using the same machinery. This rigid approach can lead to duplicated licensing efforts and significant delays in bringing products to market.
Testing Costs Skyrocket
Beyond licensing, testing costs add to the burden, with per-variant tests costing ₹22,000 to ₹25,000. Industry experts highlight that for a single batch of 29 screw samples, testing costs alone reached approximately ₹16.5 lakh, a figure comparable to establishing a dedicated laboratory. Globally, fastener standards are governed by organizations like ISO and DIN, but India's Bureau of Indian Standards (BIS) certification process is proving to be a significant impediment. Previous recommendations from the Gauba Committee and findings by the Directorate General of Trade Remedies (DGTR) have not led to policy changes.
Government Reviews Rules, Easing Possible
The government is reportedly reviewing these QCOs, particularly for steel-linked sectors, and is considering "calibrated relaxation" rather than a complete repeal. This response comes amid sustained industry pressure over supply disruptions and compliance expenses. While a full withdrawal is unlikely, procedural relaxations and deadline extensions are being explored, especially for firms meeting quality benchmarks.
